Request More Information

Register to receive helpful information and get your free Welcome Kit

CSL Behring provides a wide array of resources to help you understand your current treatment options and discuss your path forward with your doctor, including a Welcome Kit and periodic emails to provide you with additional information and support.

Please complete the form below to request materials and information about Hizentra.

If you have a question about a medical condition, consult with a healthcare professional. In the case of an emergency, call 911.

I'm living with:

CIDP PI

I would like to:

Only sign up for email updates
Request a Welcome Kit
Select a kit
- Hizentra Welcome Kit This kit provides important resources to help you start and stay on Hizentra
- Child Convenience Kit This kit provides important resources to help your child start and stay on Hizentra
Request replacement materials

Select which materials you need replaced

Hizentra Step-by-Step Infusion Guide Hizentra Therapy Journal Hizentra Patient Support Services Brochure Hizentra Infusion Placemat Hizentra Patient Brochure Hizentra Pen and Hot/Cold Pack Our Immune System Storybook ZeeZee the Chimp & Therapeutic Play Pack

I'm a:

Patient Caregiver

Are you or a loved one currently using (or about to start using) Hizentra?

Are you currently using (or about to start using) Hizentra?

Is the person you're caring for currently using (or about to start using) Hizentra?

Yes No

What product type are you using?

What type of product is the person you're caring for currently using?

SCIg IVIg Neither

Contact information

First name

Last name

Email address

Address line 1

Why are you asking for my address?

To provide the best experience for you, CSL Behring would like to maintain a record of your address so you don’t have to fill out additional forms like this one each time you want to request additional information or materials.

We will NOT

use your address to send you unsolicited promotional materials
sell your information to anyone, ever

View our Privacy Policy for more information.

+ Address Line 2

Address line 2 Optional

City

State

ZIP code

Doctor's name

Doctor's full name Optional

Doctor's office location

City Optional

State Optional

CSL Behring understands any privacy concerns, and will not seek to contact your physician regarding you or your treatment. View our Privacy Policy for more information.

By submitting this form, you are consenting to receive an email response with relevant information from CSL Behring. You may also receive relevant information from CSL Behring in the future. You will have the ability to opt out from receiving CSL Behring emails or mailings at any time. View our Privacy Policy.

Hizentra Home
About Hizentra
Starting Hizentra
- Tips for Getting Started
- Self-administering Hizentra
Support & Resources
Understanding PI/CIDP
Frequently Asked Questions

Request Info
Go to Healthcare Professionals Site
Contact Us
About CSL Behring

Top of Page

Important Safety Information

WARNING: Thrombosis (blood clots) can occur with immune globulin products, including Hizentra. Risk factors can include: advanced age, prolonged immobilization, a history of blood clotting or hyperviscosity (blood thickness), use of estrogens, installed vascular catheters, and cardiovascular risk factors.

If you are at high risk of blood clots, your doctor will prescribe Hizentra at the minimum dose and infusion rate practicable and will monitor for signs of clotting events and hyperviscosity. Always drink sufficient fluids before infusing Hizentra.

See your doctor for a full explanation, and the full prescribing information for complete boxed warning.

Hizentra^®, Immune Globulin Subcutaneous (Human), 20% Liquid, is a prescription medicine used to treat:

Primary immune deficiency (PI) in patients 2 years and older
Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

Treatment with Hizentra might not be possible if your doctor determines you have hyperprolinemia (too much proline in the blood), or are IgA-deficient with antibodies to IgA and a history of hypersensitivity. Tell your doctor if you have previously had a severe allergic reaction (including anaphylaxis) to the administration of human immune globulin. Tell your doctor right away or go to the emergency room if you have hives, trouble breathing, wheezing, dizziness, or fainting. These could be signs of a bad allergic reaction.

Inform your doctor of any medications you are taking, as well as any medical conditions you may have had, especially if you have a history of diseases related to the heart or blood vessels, or have been immobile for some time. Inform your physician if you are pregnant or nursing, or plan to become pregnant.

Infuse Hizentra under your skin only; do not inject into a blood vessel. Self-administer Hizentra only after having been taught to do so by your doctor or other healthcare professional, and having received dosing instructions for treating your condition.

Immediately report to your physician any of the following symptoms, which could be signs of serious adverse reactions to Hizentra:

Reduced urination, sudden weight gain, or swelling in your legs (possible signs of a kidney problem).
Pain and/or swelling or discoloration of an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, or numbness/weakness on one side of the body (possible signs of a blood clot).
Bad headache with nausea; vomiting; stiff neck; fever; and sensitivity to light (possible signs of meningitis).
Brown or red urine; rapid heart rate; yellowing of the skin or eyes; chest pains or breathing trouble; fever over 100°F (possible symptoms of other conditions that require prompt treatment).

Hizentra is made from human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent and its variant (vCJD), cannot be completely eliminated.

The most common side effects in the clinical trials for Hizentra include redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible. Tell your doctor about any side effect that bothers you or does not go away.

Before receiving any vaccine, tell immunizing physician if you have had recent therapy with Hizentra, as effectiveness of the vaccine could be compromised.

Please see full prescribing information for Hizentra, including boxed warning and the patient product information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Hizentra is manufactured by CSL Behring AG and distributed by CSL Behring LLC.
Hizentra^® and MyHizentra^® are registered trademarks of CSL Behring AG.
Biotherapies for Life^® and IgIQ^® are registered trademarks of CSL Behring LLC.
CSL Behring Assurance^SM and Premier Start^SM are service marks of CSL Behring LLC.
Voice2Voice^® is a registered trademark of CSL Behring GmbH.

Cuvitru and HyQuvia are trademarks of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.
©2019 CSL Behring LLC. The product information presented on this site is intended for US residents only. HIZ-0843-MAR19

You are now leaving the current website.

Do you want to continue?

No Yes